RxDoctor Payments Data

Richard Mullin, MD

Psychiatry · New York, NYNPI 1851598668

Payments from drug & device makers

$2,188in general payments, 2019–2025

Across 141 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$781
  • Corium, LLC$166
  • Alkermes, Inc.$158
  • Neurocrine Biosciences, Inc.$151
  • Tris Pharma Inc$136
  • Ironshore Pharmaceuticals Inc.$130
  • plus $666 from 16 others

What the payments were for

  • Food & beverage$2,188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,188 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$18,174
Medicare patients
51
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$15,656
VyvanseLisdexamfetamine Dimesylate18$6,935
Aripiprazole67$1,976
Bupropion XlBupropion Hcl56$1,040
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine32$871
Clonazepam56$835
Duloxetine Hcl61$773
Olanzapine42$713
Trazodone Hcl81$702
Buspirone Hcl39$683
Fluoxetine Hcl66$677
Sertraline Hcl69$601
Methylphenidate ErMethylphenidate Hcl12$503
Lorazepam110$494
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine27$445

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$781$15,65611 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$68$6,93518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →